The growing incidence of chronic kidney disease is creating increased demand for alfacalcidol-based therapies. These treatments help manage calcium and phosphate balance and support bone health in patients with impaired vitamin D metabolism. Rising awareness of mineral and bone disorders is expected to strengthen the Alfacalcidol Market. According to The Insight Partners, The Alfacalcidol...